Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Around one-third reported daily sun exposure of 15 min or more, and 6.8% had undergone a DEXA scan (Table 4).Distribution of protective and risk: driven behaviors and their associations with major and hip osteoporotic fracture risk among studied Egyptian participants.VariablesTotalMajor fracture Hip fractureN = 2242Median (Mean ± SD; Range) Median (Mean ± SD; Range)F (%)Osteoporosis medications (other than Ca & Vit D)Yes: 169 (7.5%)3.8 (5.9 ± 5.6; 0.6 to 35)0.4 (1.6 ± 3.8; 0 to 29)No: 2072 (92.4%)2.6 (3.7 ± 3.5; 0.1 to 40.8)0.2 (0.6 ± 1.4; 0 to 22)p-value•< 0.001*< 0.001*Vitamin D supplementationNo: 1583 (70.6%)2.5 (3.6 ± 3.0; 0.1 to 32)0.2 (0.6 ± 1.4; 0 to 22)Irregular: 401 (17.9%) 2.7 (4.2 ± 4.4; 0.1 to 35)0.2 (0.8 ± 2.2; 0 to 29)Regular: 257 (11.5%)3.7 (5.5 ± 5.5; 0.6 to 40.1)0.3 (1.1 ± 2.2; 0 to 22)p-value••< 0.001*< 0.001*Calcium supplementationNo: 1675 (74.7%)2.5 (3.5 ± 3.1; 0.1 to 40.8)0.2 (0.6 ± 1.4; 0 to 22)Irregular: 367 (16.4%)2.8 (4.5 ± 4.9; 0.6 to 35)0.2 (0.9 ± 2.6; 0 to 29)Regular: 200 (8.9%)4.2 (5.7 ± 4.9; 0.8 to 27)0.4 (1.2 ± 1.9; 0 to 13)p-value••< 0.001*< 0.001*Physical activityNever: 939 (41.9%)2.8 (4.2 ± 3.8; 0.1 to 29)0.2 (0.8 ± 1.9; 0 to 22)1 to 2x/week: 570 (25.4%)2.5 (3.7 ± 3.7; 0.8 to 35)0.2 (0.6 ± 1.9; 0 to 29)3 to 4x/week: 372 (16.6%) 2.6 (3.6 ± 3.4; 0.9 to 40.8)0.2 (0.5 ± 1.1; 0 to 13)≥5x/week: 361 (16.1%)2.6 (3.7 ± 3.9; 0.1 to 32)0.2 (0.5 ± 1.0; 0 to 10)p-value••0.004**< 0.001*Milk/derivatives per day> 3 servings: 48 (2.1%)2.6 (3.1 ± 2.0; 0.8 to 11) 0.2 (0.7 ± 0.8; 0.1 to 4.5)3 servings: 90 (4.0%)2.9 (4.1 ± 4.6; 0.1 to 27)0.3 (0.7 ± 2.0; 0 to 13)2 servings: 309 (13.8%)2.6 (3.9 ± 3.8; 1 to 40.8)0.2 (0.5 ± 0.9; 0 to 6.9)1 serving: 1567 (69.9%)2.6 (3.9 ± 3.7; 0.1 to 35)0.2 (0.7 ± 1.9; 0 to 29)Never: 227 (10.1%)2.4 (3.7 ± 3.3; 0.7 to 25)0.2 (0.5 ± 0.9; 0 to 7)p-value••0.610.39BMI (kg/m2)Underweight: 35 (1.6%)3.0 (4.3 ± 3.4; 1.2 to 14)0.5 (1.1 ± 1.4; 0 to 5.1)Normal: 524 (23.4%) 2.7 (3.9 ± 3.4; 0.7 to 35)0.2 (0.8 ± 1.8; 0 to 29)Overweight: 715 (31.9%)2.6 (4.1 ± 4.1; 0.8 to 32)0.2 (0.7 ± 1.8; 0 to 22)Obese: 856 (38.2%)2.5 (3.7 ± 3.4; 0.1 to 30)0.2 (0.6 ± 1.5; 0 to 22)Morbid obesity: 113 (5.0%)2.6 (3.9 ± 4.5; 0.8 to 40.8)0.2 (0.7 ± 2.3; 0 to 22)p-value••0.04*0.01*Sun exposure (15 min/day)Never: 411 (18.3%)2.6 (3.9 ± 3.4; 0.8 to 27)0.2 (0.6 ± 1.2; 0 to 13)1 to 2x/week: 492 (21.9%)2.5 (3.5 ± 2.8; 0.1 to 25)0.2 (0.6 ± 1.4; 0 to 22)3 to 4x/week: 550 (24.5%) 2.7 (4.1 ± 3.9; 0.6 to 29)0.2 (0.8 ± 1.8; 0 to 22)≥5x/week: 789 (35.2%)2.6 (4.1 ± 4.1; 0.1 to 40.8)0.2 (0.7 ± 1.9; 0 to 29)p-value••0.810.76Eggs/dairy (yogurt, cheese, labneh)Never: 125 (5.6%)2.6 (3.7 ± 3.4; 0.9 to 25)0.2 (0.6 ± 1.4; 0 to 13)1 to 2x/week: 668 (29.8%)2.6 (3.8 ± 3.5; 0.1 to 32)0.2 (0.6 ± 1.2; 0 to 15)3 to 4x/week: 790 (35.2%) ≥5x/week: 659 (29.4%)2.6 (3.9 ± 3.9; 0.6 to 30)0.2 (0.7 ± 1.8; 0 to 22)2.7 (3.9 ± 3.7; 0.1 to 40.8)0.2 (0.7 ± 1.9; 0 to 29)p-value••0.820.66DEXA scanNo: 1708 (76.2%)2.5 (3.6 ± 3.4; 0.1 to 40.8) 0.2 (0.5 ± 1.2; 0 to 22)Don’t know: 381 (17.0%)3.0 (4.5 ± 4.4; 0.7 to 35) 0.3 (1.0 ± 2.6; 0 to 29)Yes: 153 (6.8%)4.7 (5.7 ± 4.7; 0.6 to 28)0.5 (1.4 ± 3.1; 0 to 22)p-value••< 0.001*< 0.001*•Mann-WhitneyU ••Test The Kruskal-Wallis Test.*Significant at ≤0.05.

Source: Protective behaviors among the studied Egyptian participants. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The calculated sample size for women was 316, and 263 for men, considering 30% non-respondents, so the total sample was 753.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

FRAX-based national survey of osteoporotic fracture risk, related knowledge, and associated factors, among Egyptian adults aged 40 years and older, 2025

Study design awaiting verification · Scientific Reports · 2026

Original publication title

FRAX-based national survey of osteoporotic fracture risk, related knowledge, and associated factors, among Egyptian adults aged 40 years and older, 2025

Doaa I. Omar; Samar A. Amer; Shimaa Gamal Mohammed; Ahmed Abdelwahab Elsheik; Saad Abdelrahim Shoulah; Ibrahim Saeed Aljulaymi; Ibrahim Metwally Dewir; Mai Magdy Anwer

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Osteoporosis is a silent, progressive condition; however, it can be prevented and managed. The assessment of 10-year fracture risk can predict long-term osteoporotic fracture risk. This study was designed to examine osteoporotic fracture risk, its associated factors, and related knowledge among Egyptian adults aged 40+ from the 1st of April 2025 to the 1st of July 2025. This national survey included 2,242 participants over 40 years old from different regions in Egypt, using a questionnaire with five parts, including the OKAT questionnaire and the online FRAX tool, which was filled out by an interviewer.

The mean age of participants was 50.6 years, ranging from 40 to 90 years, and the mean BMI was 29.9 (± 5.6) kg/m². 2% and 4.1% were at high risk for major and hip fractures, respectively. The risk of hip and major osteoporotic fractures was significantly associated with long-term cortisone use, smoking, how long someone has smoked, higher consumption of soft or energy drinks, as well as early menopause and using hormonal contraceptives among the women in the study. 58.7% had a poor knowledge level.

The OKAT score showed a negative correlation with fracture risks, significant only for hip fracture (p = 0.007). A strong positive correlation was found between major and hip fracture risks. Most studied adult Egyptian participants had significant knowledge gaps and misconceptions, a high prevalence of risk factors, and inadequate preventive practices. Therefore, it is important to emphasize the necessity for targeted educational interventions and screening through reliable sources to reduce the future burden of osteoporosis.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-40443-4.

Authors’ abstract

Osteoporosis is a silent, progressive condition; however, it can be prevented and managed. The assessment of 10-year fracture risk can predict long-term osteoporotic fracture risk. This study was designed to examine osteoporotic fracture risk, its associated factors, and related knowledge among Egyptian adults aged 40+ from the 1st of April 2025 to the 1st of July 2025. This national survey included 2,242 participants over 40 years old from different regions in Egypt, using a questionnaire with five parts, including the OKAT questionnaire and the online FRAX tool, which was filled out by an interviewer.

The mean age of participants was 50.6 years, ranging from 40 to 90 years, and the mean BMI was 29.9 (± 5.6) kg/m². 2% and 4.1% were at high risk for major and hip fractures, respectively. The risk of hip and major osteoporotic fractures was significantly associated with long-term cortisone use, smoking, how long someone has smoked, higher consumption of soft or energy drinks, as well as early menopause and using hormonal contraceptives among the women in the study. 58.7% had a poor knowledge level.

The OKAT score showed a negative correlation with fracture risks, significant only for hip fracture (p = 0.007). A strong positive correlation was found between major and hip fracture risks. Most studied adult Egyptian participants had significant knowledge gaps and misconceptions, a high prevalence of risk factors, and inadequate preventive practices. Therefore, it is important to emphasize the necessity for targeted educational interventions and screening through reliable sources to reduce the future burden of osteoporosis.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-40443-4.

Publication and source details

Original title: FRAX-based national survey of osteoporotic fracture risk, related knowledge, and associated factors, among Egyptian adults aged 40 years and older, 2025

Doaa I. Omar; Samar A. Amer; Shimaa Gamal Mohammed; Ahmed Abdelwahab Elsheik; Saad Abdelrahim Shoulah; Ibrahim Saeed Aljulaymi; Ibrahim Metwally Dewir; Mai Magdy Anwer

Scientific Reports · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Zagazig University

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:19:01.502205+00:00

DOI: 10.1038/s41598-026-40443-4 · PMC13129074